A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
Farley
T J
TJ
Hudson Valley Blood Services, New York Medical College, Valhalla.
Preti
R A
RA
Ahmed
T
T
Ciavarella
D
D
D015703:Antigens, CD / Q000378:metabolism; D018952:Antigens, CD34; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology*; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000473:pathology; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods; D037102:Lectins; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D037121:Plant Lectins; D030262:Soybean Proteins; D014182:Transplantation, Autologous; D010835:Phytohemagglutinins
D015703:Antigens, CD; D018952:Antigens, CD34; D037102:Lectins; D037121:Plant Lectins; D030262:Soybean Proteins; C028824:soybean lectin; D010835:Phytohemagglutinins